Introduction:Trimetazidine dihydrochloride belongs to other cardiovascular drugs against angina pectoris. It protects the energy metabolism of cells under hypoxia or ischemia and prevents the decline of intracellular ATP level, so as to ensure the normal function of ion pump and the normal operation of transmembrane sodium potassium flow, and maintain the stability of intracellular environment.
CAS: 13171-25-0
Molecular formula: C14H24Cl2N2O3
Molecular weight: 339.26
Structural type:
Purpose: Trimetazidine dihydrochloride tablets, as an additive drug, are used for symptomatic treatment of adult patients with stable angina pectoris who are poorly controlled or intolerable to first-line anti angina pectoris treatment.